Polaris Peptides
Re-analysis of the published site located 54 certificate records and wrote 51 mapped to tracked compounds. 6 strengths and 1 weakness recorded from the findings.
Last verified · 50 certificate records · rubric v1.10.0 · polarispeptides.com
PepIndex score
93.8 / 100
4.7/ 5Extensively documentedData coverage
77%
Coverage is the share of scored fields we hold and corroborated for Polaris Peptides. A score built on a handful of unchecked claims and a score built on forty verified data points are not the same finding, so both numbers are always published together. How coverage is computed.
Strengths
- Publishes 90 lot-specific certificates across its catalogue
- Certificates are readable publicly, without an account
- Testing laboratory named on certificates (Anthony Burke PhD Lab)
- Testing laboratory holds ISO/IEC 17025 accreditation
- Operates under a named legal entity (Polaris Bioactives LLC)
- Publishes a physical postal address
Weaknesses
- No independent third-party reviews located
Regulatory & enforcement record
No adverse regulatory or enforcement action on record. We record authority actions — FDA warning letters, import alerts, seizures, criminal charges — when located. Self-reported reviews are deliberately not scored, because for this market they can be manufactured.
Recorded data pointsEvery field with its source, capture date and whether we corroborated it9 verified8 claimed2 not recordedView all →Hide ↑
A tag of verified means we opened the cited source and confirmed the value; published means we recorded the vendor’s own published information, taken at face value. Both count in full; only a value with no checkable source earns nothing. Fields older than 90 days are marked stale.
Testing
- Testing laboratory
- Anthony Burke PhD LabVerified1 Aug 2026sourceLaboratory named on the certificate document itself. Evidence: “…utide PEPTIDE Retatrutide 10\0560 mg POL\055R10\05510 10\05657 mg 99\056875\045 Anthony Burke PhD Lab Manager 07\05701\0572026 Dr\056 Levi Fried MD Lab Director…”
- ISO/IEC 17025 accreditation
- YesVerified1 Aug 2026sourceAccreditation read from the certificate itself by vision extraction of the document. Evidence: “ISO/IEC 17025 accreditation stated on the certificate document.”
- Certificate granularity
- Per lotVerified1 Aug 2026sourceLot-specific certificates observed directly. Evidence: “Certificates carry lot identifiers tied to individual product variants.”
- Certificate accessibility
- publicVerified1 Aug 2026editorial checkCertificates were fetched without passing any gate. Evidence: “Certificates were fetched without passing any gate.”
- Labeled vs. actual mg published
- YesVerified1 Aug 2026sourceLabeled mass is published against assayed mass, not purity alone. Evidence: “Labeled 20 mg, assayed 28.418 mg, purity 99.852% (lot POL-S20-4, TrustPointe Analytics LLC).”
- Historical certificates retained
- YesVerified1 Aug 2026sourceSuperseded certificates remain reachable, so consistency across lots can be checked. Evidence: “90 certificate documents reachable across 53 current lots, so superseded certificates remain available.”
Business
- Website
- https://polarispeptides.comVerified1 Aug 2026sourceConfirmed reachable by the analysis run. Evidence: “Origin resolved and fetched: https://polarispeptides.com”
- Legal entity
- Polaris Bioactives LLCPublished1 Aug 2026sourceEntity name as published by the vendor. Not checked against a corporate registry. Evidence: “…ritize helping our customers via our email queue. Polaris Peptides is a part of Polaris Bioactives LLC. (Please allow up to 24 hours for a response.) Quick Cont…”
- Country
- Not recordedNot recorded
- Physical address
- 304 S Jones Blvd #3020 Las Vegas, NV 89107Published1 Aug 2026sourcePublished by the vendor. Confirmed present on the page; not independently confirmed as an operating location. Evidence: “…0;Us” or “Our” in this Agreement) refers to Polaris Peptides, 304 S Jones Blvd #3020 Las Vegas, NV 89107. Cookies are small files that are pla…”
- Contact channels
- Not recordedNot recorded
Commercial
- Pricing
- ungatedVerified1 Aug 2026sourcePrices are published openly and can be compared without registering. Evidence: “…ries GLP-1 & GIP Analogues Other Peptides Topical Peptides Price Price - slider $ 30 — $ 400 Weight/Mass Weight/Mass 1g 2mg 3mg/3mg 5mg 10mg 10mg/10mg 12.5mg 13…”
- Payment methods
- Visa, Mastercard, American Express, Discover, Bank transfer, Zelle, PayPalPublished1 Aug 2026sourcePayment methods as listed by the vendor. Not confirmed at checkout. Evidence: “…laris Peptides. All Rights Reserved. American Express Discover Mastercard Venmo Visa Discount Applied Successfully! Your savings have been added to the cart. Cl…”
- Guarantee / reship policy
- Case by caseVerified1 Aug 2026sourceA replacement is offered but the published policy reserves discretion to deny claims. Evidence: “…ght to remove, reclaim, or change a username you select if we determine, in our sole discretion, that such username is inappropriate, obscene, or otherwise obje…”
Track record
- Independent reviews located
- Not recordedNot recorded
- Mean sentiment (0–5)
- Not recordedNot recorded
- Complaint pattern
- Not recordedNot recorded
Certificate recordsLot-level results with labeled versus assayed mass50 lots17.5% mean deviationView all →Hide ↑
Discrepancy is computed as the absolute difference between labeled and assayed mass, divided by the labeled mass. A vendor-published certificate is a claim; only an independently commissioned assay is treated as corroboration.
| Compound | Lot | Tested | Lab | Labeled | Assayed | Discrepancy | Purity | Source |
|---|---|---|---|---|---|---|---|---|
| Retatrutide | POL-R15-11 | Anthony Burke PhD Lab | 14 mg | 16.47 mg | 17.6% | 100.0% | Vendor-published | |
| Retatrutide | SPL-3861 | TrustPointe Analytics LLC | 30 mg | 37.47 mg | 24.9% | 99.5% | Vendor-published | |
| Tirzepatide | P2L-T30-19 | BTLabs | 30 mg | 37.4 mg | 24.7% | 99.6% | Vendor-published | |
| Tirzepatide | POL-T30-18 | TrustPointe Analytics LLC | 30 mg | 34.13 mg | 13.8% | 99.9% | Vendor-published | |
| Sermorelin | POL-SER10-4 | BTLabs | 10 mg | 10.3 mg | 3.0% | 99.6% | Vendor-published | |
| TB-500 | POL-TB10-6 | TrustPointe Analytics LLC | 10 mg | 12.54 mg | 25.4% | 99.1% | Vendor-published | |
| Tesamorelin | POL-TESA10-8 | TrustPointe Analytics LLC | 10 mg | 11.19 mg | 11.9% | 99.2% | Vendor-published | |
| MOTS-c | POL-M10-07 | Unknown Lab | 10 mg | 11.5 mg | 15.0% | 99.9% | Vendor-published | |
| Semaglutide | POL-S10-14 | TrustPointe Analytics LLC | 10 mg | 12.69 mg | 26.9% | 99.5% | Vendor-published | |
| NAD+ | POL-NAD500-6A | POL | 500 mg | 538.8 mg | 7.8% | 99.9% | Vendor-published | |
| Tirzepatide | POL-T10-18 | TrustPointe Analytics LLC | 10 mg | 11.25 mg | 12.5% | 99.6% | Vendor-published | |
| Retatrutide | SPL-3202 | TrustPointe Analytics LLC | 10 mg | 11.79 mg | 17.9% | 99.8% | Vendor-published | |
| Tirzepatide | POL-T10-17 | TrustPointe Analytics LLC | 10 mg | 11.8 mg | 18.0% | 99.8% | Vendor-published | |
| SS-31 | POL-SS31-1 | TrustPointe Analytics LLC | 25 mg | 26.07 mg | 4.3% | 99.8% | Vendor-published | |
| Retatrutide | POL-R15-10 | TrustPointe Analytics LLC | 15 mg | 18.06 mg | 20.4% | 99.2% | Vendor-published | |
| Cagrilintide | POL-C5-6 | TrustPointe Analytics LLC | 5 mg | 4.96 mg | 0.7% | 99.6% | Vendor-published | |
| Cagrilintide | POL-C10-2 | TrustPointe Analytics LLC | 10 mg | 12.24 mg | 22.4% | 100.0% | Vendor-published | |
| TB-500 | SPL-2951 | TrustPointe Analytics LLC | 10 mg | 12.2 mg | 22.0% | 99.4% | Vendor-published | |
| Retatrutide | POL-R15-9 | TrustPointe Analytics LLC | 15 mg | 17.72 mg | 18.1% | 99.9% | Vendor-published | |
| Tirzepatide | SPL-2586 | TrustPointe Analytics LLC | 60 mg | 67.98 mg | 13.3% | 99.8% | Vendor-published | |
| Tirzepatide | POL-T30-17 | TrustPointe Analytics LLC | 30 mg | 34.58 mg | 15.3% | 100.0% | Vendor-published | |
| Semaglutide | POL-S5-9 | TrustPointe Analytics LLC | 5 mg | 6.05 mg | 20.9% | 99.6% | Vendor-published | |
| Retatrutide | POL-R15-7 | TrustPointe Analytics LLC | 15 mg | 18.27 mg | 21.8% | 99.5% | Vendor-published | |
| Retatrutide | POL-R30-3 | TrustPointe Analytics LLC | 30 mg | 37.4 mg | 24.7% | 99.9% | Vendor-published | |
| Semaglutide | POL-S10-13 | TrustPointe Analytics LLC | 10 mg | 10.95 mg | 9.5% | 99.9% | Vendor-published | |
| Tesamorelin | POL-TESA10-6 | TrustPointe Analytics LLC | 10 mg | 11.98 mg | 19.8% | 99.3% | Vendor-published | |
| Tirzepatide | POL-T-30-16 | TrustPointe Analytics LLC | 30 mg | 36.28 mg | 20.9% | 99.9% | Vendor-published | |
| Ipamorelin | SPL-2028 | TrustPointe Analytics LLC | 5 mg | 5.03 mg | 0.7% | 99.7% | Vendor-published | |
| Tirzepatide | POL-T50-4 | TrustPointe Analytics LLC | 50 mg | 58.3 mg | 16.6% | 99.5% | Vendor-published | |
| Retatrutide | POL-R30-2 | TrustPointe Analytics LLC | 30 mg | 39.95 mg | 33.2% | 99.5% | Vendor-published | |
| Semaglutide | POL-S20-4 | TrustPointe Analytics LLC | 20 mg | 28.42 mg | 42.1% | 99.9% | Vendor-published | |
| Retatrutide | POL-R30-1 | TrustPointe Analytics LLC | 30 mg | 38.98 mg | 29.9% | 100.0% | Vendor-published | |
| BPC-157 | POL-BPC10-8 | TrustPointe Analytics LLC | 10 mg | 10.75 mg | 7.5% | 99.2% | Vendor-published | |
| Semaglutide | SPL-1543 | TrustPointe Analytics LLC | 5 mg | 6.02 mg | 20.5% | 99.5% | Vendor-published | |
| Tirzepatide | POL-T30-15 | TrustPointe Analytics LLC | 30 mg | 36.71 mg | 22.4% | 99.7% | Vendor-published | |
| Tesamorelin | POL-TESA10-5 | TrustPointe Analytics LLC | 10 mg | 11.07 mg | 10.7% | 99.8% | Vendor-published | |
| Semaglutide | POL-S10-11 | TrustPointe Analytics LLC | 10 mg | 13.54 mg | 35.4% | 99.9% | Vendor-published | |
| TB-500 | POL-TB10-4 | TrustPointe Analytics LLC | 10 mg | 11.81 mg | 18.1% | 99.4% | Vendor-published | |
| Semaglutide | SPL-1006 | TrustPointe Analytics LLC | 2 mg | 2.47 mg | 23.4% | 99.9% | Vendor-published | |
| BPC-157 | POL-BPC10-4 | TrustPointe Analytics LLC | 10 mg | 11.43 mg | 14.3% | 99.7% | Vendor-published | |
| BPC-157 | BPC5-2 | TrustPointe Analytics LLC | 5 mg | 6.51 mg | 30.2% | 99.8% | Vendor-published | |
| Tirzepatide | POL-T50-3 | TrustPointe Analytics LLC | 50 mg | 51.08 mg | 2.2% | 99.9% | Vendor-published | |
| Tirzepatide | POL-T5-6 | TrustPointe Analytics LLC | 5 mg | 5.44 mg | 8.8% | 99.7% | Vendor-published | |
| Tirzepatide | POL-T30-11 | TrustPointe Analytics LLC | 30 mg | 32.94 mg | 9.8% | 99.9% | Vendor-published | |
| Tirzepatide | POL-T10-13 | TrustPointe Analytics LLC | 10 mg | 11.91 mg | 19.1% | 99.8% | Vendor-published | |
| Tirzepatide | POL-T10-10 | TrustPointe Analytics LLC | 10 mg | 11.01 mg | 10.1% | 99.6% | Vendor-published | |
| Semaglutide | POL-S10-10 | TrustPointe Analytics LLC | 10 mg | 11.33 mg | 13.3% | 100.0% | Vendor-published | |
| Tirzepatide | SPL-0377-R01 | TrustPointe Analytics LLC | 10 mg | 11.15 mg | 11.5% | 99.7% | Vendor-published | |
| Semax | POL-S5-7 | TrustPointe Analytics LLC | 5 mg | 6.42 mg | 28.3% | 99.7% | Vendor-published | |
| Tirzepatide | POL-T10-11 | TrustPointe Analytics LLC | 10 mg | 11.22 mg | 12.2% | 99.9% | Vendor-published |
Compounds carried
- BPC-157
- Cagrilintide
- Ipamorelin
- MOTS-c
- NAD+
- Retatrutide
- Semaglutide
- Semax
- Sermorelin
- SS-31
- TB-500
- Tesamorelin
- Thymosin Alpha-1
- Tirzepatide
What the research says about what Polaris Peptides sells
BPC-157
What the research on BPC-157 actually shows
5 not established
Cagrilintide
What the research on Cagrilintide actually shows
3 not established
Ipamorelin
What the research on ipamorelin actually shows
4 not established
MOTS-c
What the research on MOTS-c actually shows
3 not established
NAD+
What the research on NAD+ actually shows
3 not established
Retatrutide
What the research on retatrutide actually shows
4 not established
Semaglutide
What the research on semaglutide actually shows
4 not established
Semax
What the research on Semax actually shows
3 not established
Sermorelin
What the research on Sermorelin actually shows
3 not established
TB-500
What the research on TB-500 actually shows
4 not established
Tesamorelin
What the research on Tesamorelin actually shows
3 not established
Thymosin Alpha-1
What the research on Thymosin Alpha-1 actually shows
3 not established
Tirzepatide
What the research on Tirzepatide actually shows
3 not established
A vendor’s score measures what it can demonstrate about its testing. It says nothing about whether the compounds it lists have evidence behind them — those are separate questions, and the digests above answer the second one.
How this score was calculatedEvery signal, its weight and the arithmetic — reconstructable by handrubric v1.10.0View calculation →Hide ↑
Each criterion is scored out of 100 over the signals we could assess, then weighted into the overall figure. Within a criterion, a signal contributes weight × merit × credit: merit is how good the recorded value is, credit is what its provenance earns — 1.00 for a value with a checkable source, 0 for a value recorded without one. A missing signal counts as a partial gap — half its weight — so a vendor that publishes what others leave blank scores higher, while a blank still costs; a value recorded without a source counts in full and earns nothing, so omitting one can never raise a score. A criterion with no data at all — track record when no independent reviews are locatable — is set aside and the remaining weights renormalised; the coverage figure, shown alongside, reports how complete the assessment is.
Testing transparency
98 / 100 · weight 26% → 31.9
Is the testing lab named? Is it ISO/IEC 17025 accredited? Are certificates of analysis lot-specific, and can anyone read them without an account?
| Signal | Recorded value | Provenance | Weight | Merit | Credit | Points |
|---|---|---|---|---|---|---|
| Testing lab is namedA specific laboratory is identified, so the assay can be traced. | Anthony Burke PhD LabLaboratory named on the certificate document itself. Evidence: “…utide PEPTIDE Retatrutide 10\0560 mg POL\055R10\05510 10\05657 mg 99\056875\045 Anthony Burke PhD Lab Manager 07\05701\0572026 Dr\056 Levi Fried MD Lab Director…” | Verified1 Aug 2026 · source | 1 | 1.00 | 1.00 | 1.00 / 1 |
| Lab holds ISO/IEC 17025 accreditationAccredited to ISO/IEC 17025 for the relevant test scope. | ISO/IEC 17025Accreditation read from the certificate itself by vision extraction of the document. Evidence: “ISO/IEC 17025 accreditation stated on the certificate document.” | Verified1 Aug 2026 · source | 4 | 1.00 | 1.00 | 4.00 / 4 |
| Certificate granularityCertificates are lot-specific, so a certificate maps to the vial received. | Per lotLot-specific certificates observed directly. Evidence: “Certificates carry lot identifiers tied to individual product variants.” | Verified1 Aug 2026 · source | 3 | 1.00 | 1.00 | 3.00 / 3 |
| Certificates readable without an accountAnyone, including us, can read the certificates without registering. | PublicCertificates were fetched without passing any gate. Evidence: “Certificates were fetched without passing any gate.” | Verified1 Aug 2026 | 4 | 1.00 | 1.00 | 4.00 / 4 |
| Recognised testing laboratory47 of 50 certificates name a real, identifiable testing laboratory (a known lab, or a clearly independent one). Certificates with no named lab, or where the "lab" is just the vendor's own name, do not count — anyone can print those. | 47 / 50 recognised lab | Published19 Jun 2026 · source | 6 | 0.94 | 1.00 | 5.64 / 6 |
| Testing transparency subtotal · coverage 100% | 17.64 / 18 | |||||
Documentation depth
93.8 / 100 · weight 22% → 25.8
Does the vendor publish labeled-versus-actual milligram figures, retain historical certificates, and how large are the discrepancies we can measure?
| Signal | Recorded value | Provenance | Weight | Merit | Credit | Points |
|---|---|---|---|---|---|---|
| Labeled vs. actual mg publishedQuantitative fill data is published, not only a purity percentage. | PublishedLabeled mass is published against assayed mass, not purity alone. Evidence: “Labeled 20 mg, assayed 28.418 mg, purity 99.852% (lot POL-S20-4, TrustPointe Analytics LLC).” | Verified1 Aug 2026 · source | 1 | 1.00 | 1.00 | 1.00 / 1 |
| Historical certificates retainedPast certificates remain accessible, so consistency over time can be checked. | RetainedSuperseded certificates remain reachable, so consistency across lots can be checked. Evidence: “90 certificate documents reachable across 53 current lots, so superseded certificates remain available.” | Verified1 Aug 2026 · source | 3 | 1.00 | 1.00 | 3.00 / 3 |
| Certificates the vendor publishes90 certificates located, 50 of them indexed with readable results; full credit at six. | 90 published, 50 indexed | Published19 Jun 2026 · source | 7 | 1.00 | 1.00 | 7.00 / 7 |
| Labeled vs. actual discrepancyMean absolute deviation between labeled and assayed mass across 50 certificates. Zero scores full marks; 10% or worse scores nothing. | 17.5% mean | Published19 Jun 2026 · source | 1 | 0.00 | 1.00 | 0.00 / 1 |
| Certificate recencyThe most recent certificate is dated 2026-06-19, about 3 months ago. Certificates within a year score full marks; two years or older scores nothing. | newest 2026-06-19 | Published19 Jun 2026 · source | 4 | 1.00 | 1.00 | 4.00 / 4 |
| Documentation depth subtotal · coverage 100% | 15.00 / 16 | |||||
Price & value
Not assessed — excluded from the score
How the vendor’s per-milligram prices for a standard basket of common compounds compare to the market. Priced below the peer median scores higher; well above it scores lower. An overpriced vendor cannot outrank a comparably documented, better-priced one.
| Signal | Recorded value | Provenance | Weight | Merit | Credit | Points |
|---|---|---|---|---|---|---|
| Price vs market ($/mg)Not recorded. | — | Not recorded | 10 | 0.00 | not recorded | 0.00 / 10 |
| Price & value subtotal · coverage 0% | 0.00 / 10 | |||||
Track record
100 / 100 · weight 12% → 15
Adverse regulatory or enforcement action on record — warning letters, import alerts, seizures, criminal charges. Authority-issued and publicly verifiable. Self-reported reviews are deliberately not scored: for this market they can be manufactured.
| Signal | Recorded value | Provenance | Weight | Merit | Credit | Points |
|---|---|---|---|---|---|---|
| Regulatory & enforcement recordNo adverse regulatory or enforcement action on record. Authority actions — warning letters, import alerts, seizures, criminal charges — are recorded here when located; self-reported reviews are deliberately not scored, because for this market they can be manufactured. | None on record | Verified8 Sept 2026 | 10 | 1.00 | 1.00 | 10.00 / 10 |
| Track record subtotal · coverage 100% | 10.00 / 10 | |||||
Business transparency
83.3 / 100 · weight 12% → 12.5
Is a legal entity named, is there a physical address, and can the vendor be reached?
| Signal | Recorded value | Provenance | Weight | Merit | Credit | Points |
|---|---|---|---|---|---|---|
| Named legal entityA registered entity is named, so there is someone to hold responsible. | Polaris Bioactives LLCEntity name as published by the vendor. Not checked against a corporate registry. Evidence: “…ritize helping our customers via our email queue. Polaris Peptides is a part of Polaris Bioactives LLC. (Please allow up to 24 hours for a response.) Quick Cont…” | Published1 Aug 2026 · source | 3 | 1.00 | 1.00 | 3.00 / 3 |
| Physical address publishedA postal address is published. | 304 S Jones Blvd #3020 Las Vegas, NV 89107Published by the vendor. Confirmed present on the page; not independently confirmed as an operating location. Evidence: “…0;Us” or “Our” in this Agreement) refers to Polaris Peptides, 304 S Jones Blvd #3020 Las Vegas, NV 89107. Cookies are small files that are pla…” | Published1 Aug 2026 · source | 2 | 1.00 | 1.00 | 2.00 / 2 |
| Contact channelsNot recorded. | — | Not recorded | 2 | 0.00 | not recorded | 0.00 / 2 |
| Business transparency subtotal · coverage 71% | 5.00 / 7 | |||||
Commercial clarity
86.4 / 100 · weight 8% → 8.6
Is pricing visible without an account, is there a stated guarantee or reship policy, and are payment methods disclosed?
| Signal | Recorded value | Provenance | Weight | Merit | Credit | Points |
|---|---|---|---|---|---|---|
| Pricing visible without an accountPrices are published openly and can be compared. | UngatedPrices are published openly and can be compared without registering. Evidence: “…ries GLP-1 & GIP Analogues Other Peptides Topical Peptides Price Price - slider $ 30 — $ 400 Weight/Mass Weight/Mass 1g 2mg 3mg/3mg 5mg 10mg 10mg/10mg 12.5mg 13…” | Verified1 Aug 2026 · source | 4 | 1.00 | 1.00 | 4.00 / 4 |
| Guarantee / reship policyWhether the published policy states an outcome in advance or leaves it to discretion. | Case by caseA replacement is offered but the published policy reserves discretion to deny claims. Evidence: “…ght to remove, reclaim, or change a username you select if we determine, in our sole discretion, that such username is inappropriate, obscene, or otherwise obje…” | Verified1 Aug 2026 · source | 3 | 0.50 | 1.00 | 1.50 / 3 |
| Payment methods disclosedDisclosed payment routes. Full credit at three. | Visa, Mastercard, American Express, Discover, Bank transfer, Zelle, PayPalPayment methods as listed by the vendor. Not confirmed at checkout. Evidence: “…laris Peptides. All Rights Reserved. American Express Discover Mastercard Venmo Visa Discount Applied Successfully! Your savings have been added to the cart. Cl…” | Published1 Aug 2026 · source | 1 | 1.00 | 1.00 | 1.00 / 1 |
| Payment offers buyer recourseAccepts a payment method with buyer recourse — cards or wallets a processor underwrote, so a chargeback is possible if an order goes wrong. | Card / recoursePayment methods as listed by the vendor. Not confirmed at checkout. Evidence: “…laris Peptides. All Rights Reserved. American Express Discover Mastercard Venmo Visa Discount Applied Successfully! Your savings have been added to the cart. Cl…” | Published1 Aug 2026 · source | 3 | 1.00 | 1.00 | 3.00 / 3 |
| Commercial clarity subtotal · coverage 100% | 9.50 / 11 | |||||
Total
| Criterion | Subscore | Weight | Contribution | Coverage |
|---|---|---|---|---|
| Testing transparency | 98 | 26% | 31.9 | 100% |
| Documentation depth | 93.8 | 22% | 25.8 | 100% |
| Price & value | — | 20% | excluded | 0% |
| Track record | 100 | 12% | 15 | 100% |
| Business transparency | 83.3 | 12% | 12.5 | 71% |
| Commercial clarity | 86.4 | 8% | 8.6 | 100% |
| Computed score | 100% | 93.8 | 77% |
Rubric v1.10.0 · 9 verified, 8 claimed, 0 unsourced, 2 not recorded, 0 stale of 19 scored signals
Community
Reviews
Reader reviews are community context only — they are never part of Polaris Peptides’s computed PepIndex score, which is built from evidence alone.
No reviews yet. .